Category Archives: Cell Biology

Stem Cell Therapy Contract Manufacturing Industry, 2019-2030 – Availability of Cutting-Edge Tools & Technologies has Emerged as a Differentiating…

Dublin, Feb. 17, 2020 (GLOBE NEWSWIRE) -- The "Stem Cell Therapy Contract Manufacturing Market, 2019-2030" report has been added to ResearchAndMarkets.com's offering.

This report features an extensive study on contract service providers engaged in the development and manufacturing of stem cell therapies. The study features in-depth analyses, highlighting the capabilities of various stem cell therapy CMOs

Advances in the fields of cell biology and regenerative medicine have led to the development of a variety of stem cell-based therapies for many cardiovascular, oncological, metabolic and musculoskeletal disorders. Driven by the revenues generated from stem cell therapies, the regenerative medicine market is anticipated to generate revenues worth USD 100 billion by 2030.

With a promising pipeline of over 200 stem cell therapy candidates, it has become essential for developers to scale up the production of such therapeutic interventions. Given that stem cell therapy manufacturing requires highly regulated, state-of-the-art technologies, it is difficult for stakeholders to establish in-house expertise for large-scale manufacturing of stem cell therapies.

As a result, stem cell therapy developers have begun outsourcing their manufacturing operations to contract manufacturing organizations (CMOs). Specifically, small and mid-sized players in this sector tend to outsource a substantial proportion of clinical and commercial-scale manufacturing processes to contract service providers. In addition, even big pharma players, with established in-house capabilities, are gradually entering into long-term business relationships with CMOs in order to optimize resource utilization and manage costs.

According to a recent Nice Insight CDMO survey, about 55% of 700 respondents claimed to have collaborated with a contract service provider for clinical and commercial-scale product development requirements. Considering the prevalent trends, we believe that the stem cell therapy manufacturing market is poised to grow at a steady pace, driven by a robust pipeline of therapy candidates and technological advances aimed at mitigating challenges posed by conventional methods of production. Amidst tough competition, the availability of cutting-edge tools and technologies has emerged as a differentiating factor and is likely to grant a competitive advantage to certain CMOs over other players in the industry.

One of the key objectives of the report was to estimate the future size of the market. Based on parameters, such as increase in number of clinical studies, target patient population, anticipated adoption of stem cell therapies and expected variation in manufacturing costs, we have provided an informed estimate of the likely evolution of the market in the mid to long term, for the period 2019-2030.

Amongst other elements, the report includes:

In order to provide a detailed future outlook, our projections have been segmented on the basis of:

Key Topics Covered

1. Preface

2. Executive Summary

3. Introduction

4. Market Overview

5. Regulatory Landscape

6. Stem Cell Therapy Contract Manufacturers in North America

7. Stem Cell Therapy Contract Manufacturers in Europe and Asia-Pacific

8. Partnerships and Collaboration

9. Contract Manufacturing Opportunity Assessment

10. Capacity Analysis

11. Demand Analysis

12. Market Forecast

13. Key Performance Indicators

14. Concluding Remark

15. Executive Insights

16. Appendix 1: Tabulated Data

17. Appendix 2: List of Companies and Organizations

For more information about this report visit https://www.researchandmarkets.com/r/rktm8d

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.comLaura Wood, Senior Press Managerpress@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900

Continued here:
Stem Cell Therapy Contract Manufacturing Industry, 2019-2030 - Availability of Cutting-Edge Tools & Technologies has Emerged as a Differentiating...

Synthetic Biology Market to Witness a CAGR of 23.9% Through 2020-2025 – Increasing Demand for Protein Therapeutics & Personalized Medicine, Increasing…

DUBLIN, Feb. 17, 2020 /PRNewswire/ -- The "Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), by Technology (Gene Synthesis, Bioinformatics), by Application (Tissue Regeneration, Biofuel, Renewable Energy, Food & Agriculture, Bioremediation) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The global synthetic biology market is projected to reach USD 19.8 billion by 2025 from USD 6.8 billion in 2020, at a CAGR of 23.9%.

This report analyzes the market for various synthetic biology market and their adoption patterns. It aims at estimating the market size and future growth potential of the synthetic biology market and its subsegments. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.

Factors such as the increasing demand for synthetic genes and synthetic cells, wide range of applications of synthetic biology, declining cost of DNA sequencing and synthesizing, increasing R&D funding and initiatives in synthetic biology, and increasing investments in the market are propelling the growth of this market. However, rising biosafety, biosecurity, and ethical concerns related to synthetic biology are likely to hamper the growth of this market.

The oligonucleotides and synthetic DNA segment is expected to grow at the highest rate during the forecast period

Based on tools, the market has been segmented into oligonucleotides and synthetic DNA, enzymes, cloning technology kits, chassis organisms, xeno-nucleic acids, and synthetic cells. In 2019, the oligonucleotides and synthetic DNA segment is expected to register the highest CAGR during the forecast period.

This can be attributed to factors such as the rising demand for synthetic DNA, synthetic RNA, and synthetic genes, which are used in a wide range of applications, such as pharmaceuticals, nutraceuticals, personal care, flavors and fragrances, probiotics, green chemicals, and industrial enzymes.

The genome engineering segment is expected to grow at the highest CAGR during the forecast period

On the basis of technology, the market is segmented into gene synthesis, genome engineering, cloning, sequencing, site-directed mutagenesis, measurement and modeling, microfluidics, nanotechnology, bioinformatics technologies.

The genome engineering segment is expected to register the highest CAGR during the forecast period due to factors such as the increasing use of engineering technologies for manipulating complex genomes, growing therapeutics development for cancer and other diseases, and the increasing technological advances in CRISPR-toolbox and DNA synthesis technologies.

The industrial applications segment is expected to grow at the highest CAGR during the forecast period

Based on application, the synthetic biology market is segmented into medical, industrial, food & agricultural, and environmental applications. The industrial applications segment is expected to grow at the highest CAGR owing to the rising applications of synthetic biology in producing renewable energy, biomaterials & green chemicals, and enzymes.

The Asia Pacific is projected to witness the highest growth during the forecast period

The synthetic biology market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2019, North America accounted for the largest share of the synthetic biology market.

However, the APAC region is expected to witness the highest growth during the forecast period owing to the growth in the number of pharmaceutical & biopharmaceutical companies, the increasing number of healthcare & life science facilities, and increasing requirements for regulatory compliance in pharmaceutical and biopharmaceutical companies, growing number of international alliances, heavy funding for synthetic biology research, and strong government support.

Furthermore, the increasing focus on the Asia Pacific markets due to their low-cost manufacturing advantage also provides growth opportunities for manufacturers.

Key Topics Covered

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights 4.1 Market Overview4.2 Asia Pacific: Market, By Application4.3 Market: Geographic Growth Opportunities4.4 Market, By Region (2018-2025)4.5 Market: Developed vs. Developing Markets

5 Market Overview 5.1 Introduction5.2 Market Dynamics5.2.1 Drivers5.2.1.1 Wide Range of Applications of Synthetic Biology5.2.1.2 Rising R&D Funding and Growing Initiatives in Synthetic Biology5.2.1.3 Declining Cost of DNA Sequencing and Synthesizing5.2.1.4 Increasing Investments in the Market5.2.2 Restraints5.2.2.1 Biosafety, Biosecurity, and Ethical Concerns5.2.3 Opportunities5.2.3.1 Rising Need for Fuel Alternatives5.2.3.2 Increasing Demand for Protein Therapeutics and Personalized Medicine5.2.3.3 Increasing Research in Synthetic Drugs and Vaccines5.2.4 Challenges5.2.4.1 Standardization of Biological Parts

6 Synthetic Biology Market, By Tool 6.1 Introduction6.2 Oligonucleotides & Synthetic DNA6.2.1 Oligonucleotides and Synthetic Dna to Dominate the Market During the Forecast Period6.3 Enzymes6.3.1 Development of Enzymes has Helped in Evolving New Therapies for A Range of Diseases6.4 Cloning Technology Kits6.4.1 Need for the Creation of Artificial Dna Along With Their Assembly is Driving the Growth of the Segment6.5 Synthetic Cells6.5.1 Synthetic Cells Will Allow Tailoring Biologics and Its Adoption is Expected to Grow in the Coming Years6.6 Chassis Organisms6.6.1 Increasing Demand for Fossil Fuels is Likely to Propel the Demand for Chassis Organisms6.7 Xeno-Nucleic Acids6.7.1 Xnas are Increasingly Researched With the Growing Demand for Breakthrough Medicine

7 Synthetic Biology Market, By Technology 7.1 Introduction7.2 Gene Synthesis7.2.1 Gene Synthesis to Dominate the Market During the Forecast Period7.3 Genome Engineering7.3.1 Increasing Demand for Synthetic Dna and Genes is Expected to Drive Market Growth7.4 Sequencing7.4.1 Ngs Technology is Rapidly Becoming an Indispensable and Universal Tool for Biological Research7.5 Bioinformatics7.5.1 Use of Bioinformatics Technologies is Increasing With the Rising Need for Data Management and Curation7.6 Cloning7.6.1 Cloning Aids in Building New Genetic Modules/Pathways, Enabling Rapid Advances in Research Across Various Industries7.7 Site-Directed Mutagenesis7.7.1 Wide Applications in Genetic Engineering, Dna Assembly, and Cloning Technologies is Driving This Segment7.8 Measurement & Modeling7.8.1 Computational Modeling is Aiding the Growth of the Segment During the Forecast Period7.9 Microfluidics7.9.1 Droplet Microfluidics is Gaining Wide Recognition in the Field of Synthetic Biology7.1 Nanotechnology7.10.1 Convergence Between Synthetic Biology and Nanotechnologies Aid in Building Complex Bodies

8 Synthetic Biology Market, By Application 8.1 Introduction8.2 Medical Applications8.2.1 Pharmaceuticals8.2.1.1 In 2019, the Pharmaceuticals Segment Accounted for the Largest Share of the Medical Applications Market8.2.2 Drug Discovery and Therapeutics8.2.2.1 Cancer Detection & Diagnostics8.2.2.1.1 With Rising Investments for Cancer Research, the Market for Synthetic Biology is Expected to Grow for This Segment8.2.2.2 Other Drug Discovery and Therapeutic Applications8.2.3 Artificial Tissue & Tissue Regeneration8.2.3.1 Bio-Synthesis8.2.3.1.1 Bio-Synthesis is Dominating the Market With Its Increasing Adoption in Creating Artificial Genomes8.2.3.2 Stem Cell Regulation8.2.3.2.1 Use of Synthetic Biology in Stem Cell Regeneration and Reprogramming Somatic Cells is Expected to Drive Market Growth8.2.3.3 Other Artificial Tissue and Tissue Regeneration Applications8.3 Industrial Applications8.3.1 Biofuel and Renewable Energy8.3.1.1 Advantages of Using Genetically Engineered Organisms for the Synthetic Production of Biofuels is Driving Market Growth8.3.2 Industrial Enzymes8.3.2.1 Textile Industry8.3.2.1.1 Synthetic Biology is Being Applied in the Textile Industry to Replace Traditional Raw Materials8.3.2.2 Paper Industry8.3.2.2.1 Enzymes are Being Increasingly Used in the Pulp and Paper Industry8.3.2.3 Other Industries8.3.3 Biomaterials & Green Chemicals8.3.3.1 Silk-Based Proteins are A Type of Biomaterial Prepared Through Synthetic Biology8.4 Food & Agriculture8.4.1 Synthetic Biology Techniques are Applied in the Food and Agriculture Industry to Produce Metabolites, Health Products, and Processing Aids8.5 Environmental Applications8.5.1 Bioremediation8.5.1.1 Owing to the Growing Severity of Environmental Problems, It has Become Necessary to Develop Cost-Effective, On-Site Methods for Environmental Monitoring and Bioremediation8.5.2 Biosensing8.5.2.1 Biosensor Applications Commonly Make Use of Microalgae Owing to Their High Reproductive Rates and Ease of Culturing Due to Their Microscopic Size

9 Synthetic Biology Market, By Region 9.1 Introduction9.2 North America9.2.1 US9.2.1.1 The US Dominates the North American Market9.2.2 Canada9.2.2.1 Strong Research Infrastructure and Availability of Funding Will Support Market Growth9.3 Europe9.3.1 UK9.3.1.1 The UK Holds the Largest Share of the European Market9.3.2 Germany9.3.2.1 The Rapidly Growing Pharmaceutical Market is Expected to Drive Market Growth9.3.3 France9.3.3.1 Research Across All Industries is Strongly Supported By the Government9.3.4 Denmark9.3.4.1 Denmark has the Third-Largest Commercial Drug-Development Pipeline in Europe9.3.5 Switzerland9.3.5.1 Market Growth is Primarily Driven By the Well-Established Pharmaceutical & Biotechnology Industry in the Country9.3.6 Spain9.3.6.1 Spain has A Well-Established Network of Research Centers, Universities, and Hospitals, Which Form an Ideal Environment for Research9.3.7 Italy9.3.7.1 Growth in This Market is Mainly Driven By Increasing Life Science R&D in the Country, Funded By Both Public and Private Organizations9.3.8 Rest of Europe9.4 Asia Pacific9.4.1 Japan9.4.1.1 Large Number of Research Initiatives Towards the Development of Precision Medicine Supporting Market Growth9.4.2 China9.4.2.1 Growth in R&D to Enhance the Technological Capabilities in the Country, Thereby Driving the Demand for High-Quality Research Tools9.4.3 Australia9.4.3.1 Increasing Focus of the Healthcare System on Precision Medicine to Offer Significant Growth Opportunities9.4.4 India9.4.4.1 Increasing Pharma R&D and Government Funding in the Biotechnology Industry are the Major Factors Driving Market Growth9.4.5 Rest of Asia Pacific9.5 Latin America9.5.1 Strong Pharmaceutical Industry in the Region to Provide Significant Growth Opportunities9.6 Middle East and Africa9.6.1 Increasing Partnerships Among Global Players With Government Organizations in the Region to Support Growth

10 Competitive Landscape 10.1 Overview10.2 Market Share Analysis10.2.1 Synthetic Biology Market, By Key Players, 201810.3 Competitive Leadership Mapping10.3.1 Visionary Leaders10.3.2 Innovators10.3.3 Dynamic Differentiators10.3.4 Emerging Companies10.4 Competitive Situation and Trends10.4.1 Product Launches10.4.2 Expansions10.4.3 Acquisitions10.4.4 Other Strategies

11 Company Profiles 11.1 Thermo Fisher Scientific Inc.11.1.1 Business Overview11.1.2 Products Offered11.1.3 Recent Developments11.2 Merck KGaA11.3 Agilent Technologies Inc.11.4 Novozymes A/S11.5 Ginkgo Bioworks11.6 Amyris Inc.11.7 Intrexon Corporation11.8 Genscript Biotech Corporation11.9 Twist Bioscience11.10 Synthetic Genomics Inc. (SGI)11.11 Codexis Inc.11.12 Synthego Corporation11.13 Creative Enzymes11.14 Eurofins Scientific11.15 Cyrus Biotechnology Inc.11.16 Other Major Companies11.16.1 Atum11.16.2 Teselagen11.16.3 Arzeda11.16.4 Integrated DNA Technologies Inc.11.16.5 New England Biolabs

For more information about this report visit https://www.researchandmarkets.com/r/9yuhf0

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/synthetic-biology-market-to-witness-a-cagr-of-23-9-through-2020-2025---increasing-demand-for-protein-therapeutics--personalized-medicine-increasing-research-in-synthetic-drugs--vaccines-301005931.html

SOURCE Research and Markets

Here is the original post:
Synthetic Biology Market to Witness a CAGR of 23.9% Through 2020-2025 - Increasing Demand for Protein Therapeutics & Personalized Medicine, Increasing...

Cell biology storm provides a view of the choreography of life – ABC27

Credit: National Institutes of Health

Researchers found the key settings to provide a dynamic view of a cytoskeletal storm

The experimental system was designed to use cells from the African clawed frog. The movie which is represented in the GIF above begins with microtubules (red) radiating outward in an apparent effort to prepare for cell division. The microtubules adjust their lengths with the help of the protein EB-1 (green) at their tips. As the microtubules grow and bump into the walls of a lab-generated, jelly-textured enclosure (dark outline), they buckleand the whole array then whirls around the center.

Cells are constantly on the move and before a cell divides it undergoes a process called mitosis. As part of this process, microtubules, which are structural proteins that help make up the cells cytoskeleton, reorganize the newly copied chromosomes into a dense, football-shaped spindle.

The cytoskeleton is made from protein structures called microtubulesthe wispy threads surrounding the purple DNA-containing nucleusand filaments of a protein called actin. Both actin and microtubules are critical for growth and movement.

Abdullah Bashar Sami, a Ph.D. student, shot the movie as a part of his basic research to explore the still poorly understood physical forces generated by microtubules. The movie won first place in the 2019 Green Fluorescent Protein Image and Video Contest sponsored by the American Society for Cell Biology.

Like many movies, the setting was key to this videos success. The video was shot inside a microfluidic chamber, designed in the Jesse Gatlin Lab at the University of Wyoming, to study the physics of microtubule assembly just before cells divide.

Go here to read the rest:
Cell biology storm provides a view of the choreography of life - ABC27

Researchers from Houston and Newark awarded $1 million each to tackle major challenges in heart disease treatment and stroke prevention – Associated…

( NewMediaWire ) - February 14, 2020 - DALLAS - A Newark, N.J., researcher studying a new way to prevent heart injury and eventual heart failure and a Houston physician-scientist working to better understand and prevent stroke risk transmission from mother to child are the most recent American Heart Association Merit Award recipients. Each researcher will receive $1 million in funding from the Association, the worlds leading voluntary organization focused on heart and brain health and research.

Junichi Sadoshima, M.D., Ph.D., professor and chair of cell biology and molecular medicine at Rutgers New Jersey Medical School, and Louise D. McCullough, M.D., Ph.D., professor and chair of neurology at McGovern Medical School at the University of Texas Health Science Center at Houston will receive $200,000 a year for five years.

The American Heart Associations annual Merit Award aims to fuel highly promising, novel research that has the potential to move cardiovascular science forward.

With the Merit Award, we are searching for researchers with fresh ideas and the potential to make a huge impact, which is in line with the American Heart Associations mission to be a relentless force for a world of longer, healthier lives, said American Heart Association President Robert Harrington, M.D., FAHA, an interventional cardiologist and chair of the department of medicine at Stanford University in California. These exceptional scientists are asking the questions that havent been asked and are looking for answers in what we may consider to be nontraditional places. In the end, their work could transform cardiovascular and stroke science.

Sadoshimas research addresses the major public health problem that many people who have a heart attack or stroke die from heart failure or other complications within a few years after their first event. He and his colleagues are studying how inhibiting a previously uncharacterized type of cell death in the heart might prevent weakening of the heart and brain after a heart attack or stroke.

Just like we replace broken or worn-out parts in our cars to make them run better, our cells discard old or broken materials every day through a process called autophagy. While autophagy is a fundamentally important mechanism to maintain the function in the heart, the process can sometimes go awry and actually promote cellular suicide. This cell death triggered by excessive autophagy is termed autosis, Sadoshima said. Our goal with this award is to develop treatment to make the heart stronger when patients have a heart attack or stroke by understanding how autosis is stimulated and how it kills heart and brain cells.

Sadoshima said focusing on this previously uncharacterized form of cell death in the heart may have a significant impact on the future treatment of patients with reduced blood supply to the heart and brain.

McCulloughs research also looks at a big public health issue, stroke, in a new way.

It has been known for some time that health problems that occur during pregnancy, such a mothers high blood pressure, obesity or diabetes, can cause changes leading to obesity and hypertension in the child shes carrying. Initially, it was thought that a lot of this was genetic but there also are epigenetic factors outside factors that can change the genes to increase risk, McCullough said.

Prior research led McCullough and her colleagues to believe the mothers microbiome, the collection of microorganisms that reside in the gastrointestinal tract and are passed during childbirth to the child, might modify genes and increase later stroke risk in offspring. The health of the microbiome tends to change with age, becoming more likely to cause inflammation.

Were studying whether a mothers unhealthy microbiome can be manipulated and improved with diet or supplements, perhaps, to reduce stroke risk in her offspring, she said. If successful, these findings could have huge health ramifications for many generations to come.

Funding research such as the annual merit awards is a cornerstone of the American Heart Associations lifesaving mission. The Association has funded more than $4.6 billion in cardiovascular research since 1949, making it the single largest non-government supporter of heart and brain health research in the U.S.

Additional Resources:

Follow AHA/ASA news on Twitter @HeartNews

###

The American Heart Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at https://www.heart.org/en/about-us/aha-financial-information.

About the American Heart Association

The American Heart Association is a leading force for a world of longer, healthier lives. With nearly a century of lifesaving work, the Dallas-based association is dedicated to ensuring equitable health for all. We are a trustworthy source empowering people to improve their heart health, brain health and well-being. We collaborate with numerous organizations and millions of volunteers to fund innovative research, advocate for stronger public health policies, and share lifesaving resources and information. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.

For Media Inquiries and AHA/ASA Expert Perspective: 214-706-1173

Cathy Lewis: 214-706-1324; cathy.lewis@heart.org

For Public Inquiries: 1-800-AHA-USA1 (242-8721)

heart.org and strokeassociation.org

Excerpt from:
Researchers from Houston and Newark awarded $1 million each to tackle major challenges in heart disease treatment and stroke prevention - Associated...

Williston alum receives recognition for international award | Education – Williston Daily Herald

Williston native and University of Colorado Boulder Professor Kristi Anseth has received one of the most prestigious recognitions in the life sciences: a LOreal-UNESCO For Women in Science award.

Anseth, a distinguished professor and Tisone professor in the Department of Chemical and Biological Engineering, is being recognized for her outstanding contribution in converging engineering and biology to develop innovative biomaterials that help tissue regeneration and drug delivery, according to UNESCO.

She is one of only five women in the world, and the only recipient in North America, to receive the recognition this year.

I am tremendously honored and feel so very fortunate to be part of the broader University of Colorado community, Anseth said. However, I must first acknowledge that this is a shared honor. I have the pleasure of mentoring an amazing group of undergraduate students, graduate students and postdoctoral associates in my laboratory, and these individuals have contributed tremendously to the basis for this recognition. I am so thankful to them for their dedication and CUs commitment to supporting not only the education of these individuals but their transition to future leaders.

Anseth said shes eagerly anticipating the opportunity to celebrate women scientists and engineers and to play a more visible role for the next generation. The mother of a 12-year-old daughter, Anseth said she hopes her daughters generation is inspired to pursue careers in STEM and that girls see no bounds to their possible careers.

She also commended her colleagues in the Department of Chemical and Biological Engineering and the BIoFrontiers Institute for their support.

I am fortunate to work in an environment with such brilliant colleagues who work tirelessly to advance our fields and educate students to develop technologies and ideas for supporting the well-being of people, society and the planet, Anseth said.

Anseth, who is also the associate director of the BioFrontiers Institute, has a long and storied career in applying the principles of chemical engineering to the biomaterials field, authoring over 330 papers of extensive, highly impactful research and earning numerous awards and recognitions. She is one of only a handful of individuals worldwide elected to all three national academies: the National Academy of Engineering, the National Academy of Medicine and the National Academy of Sciences. She also has been elected to the American Academy of Arts and Sciences, the National Academy of Inventors and the International Academy of Medical and Biological Engineering.

Professor Anseth has proven time and again, through her stellar career of research and achievement, as well as her teaching and mentoring, that she is a world-class scientist and engineer, said Keith Molenar, interim dean of the College of Engineering and Applied Science. The LOreal-UNESCO For Women in Science awards recognize the best of the best, and she is absolutely deserving of that honor. Were proud that she calls the CU Boulder College of Engineering and Applied Science home, as she brings immeasurable value to the research and education happening here.

Kristi Anseth has been a leader in cutting-edge biomaterials research for over two decades, said Charles Musgrave, chair of the Department of Chemical and Biological Engineering. Her work in the tissue engineering and drug delivery fields has led to the development of key technologies that will have an incredible impact on regenerative medicine and drug delivery. I cant think of anyone more deserving of this award than her. My colleagues and I are proud of her many accomplishments.

Anseth is a graduate of Williston High School and attended UND-Williston before earning her doctoral degree in chemical engineering from CU Boulder in 1994 and joining the faculty shortly thereafter, focusing her research on developing biomaterials for medical applications.

Rob Davis, dean emeritus of the College of Engineering and Applied Science and Tisone endowed chair in the Department of Chemical and Biological Engineering, nominated Anseth for the award. He cited her unparalleled research accomplishments in biotechnology and cell biology and the translation of her technologies into medical products, including in-situ-forming materials for enhanced bone regeneration, hydrogels for chondrocyte delivery and more.

He also emphasized her dedication to her students, recalling his first observation of her after she completed her PhD. She had volunteered to teach an 8a.m. undergraduate course, winning over the sleepy and skeptical students with her enthusiasm and passion for the material.

Support for the nomination also came from other distinguished leaders in academia, including professors Paula T. Hammond and Robert Langer of MIT, Provost David A. Tirrell and Professor Mark E. Davis of the California Institute of Technology, and Professor Nicholas A. Peppas of the University of Texas at Austin.

Anseth and the other awardees will be honored at a ceremony March 12 at UNESCO Headquarters in Paris. Each award recipient will receive 100,000 (about $109,000). The awards seek to increase the representation and awareness of women in science and their achievements to inspire more women to consider careers in the sciences.

Continue reading here:
Williston alum receives recognition for international award | Education - Williston Daily Herald

Setting the Record Straight: Panic and Pandemics – American Libraries

On February 13, Booklist compiled a list of resources for librarians looking for information on the coronavirus and other epidemics and pandemics. The full list is reprinted below.

First reported in Wuhan, China, on December 31, the respiratory illness prompted by coronavirus (dubbed COVID-19) has since spread to 28 countries worldwide, infecting more than 60,000 individuals. Unfortunately, as cases across the globe increase, so too does the dangerous misinformation surrounding them. The below titles, about outbreaks, viruses, and vaccines, attempt to set the record straight.

The Vaccine Race: Science, Politics, and the Human Costs of Defeating Diseaseby Meredith WadmanWe tend to take vaccines and their benefits for granted until a new scare erupts, such as the Zika virus. Biomedical reporter Wadman explores in great detail the often controversial background stories of various major breakthroughs in cell biology that led to the creation of some of the worlds most important vaccines. Wadman reveals the unsung heroes behind the research as well as the medical experiments that readers will now find abhorrent. In all, an important book on a persistently controversial aspect of health care.

Virus: An Illustrated Guide to 101 Incredible Microbesby Marilyn J. RoossinckThe book begins with a history and time line of virology and a discussion of the life cycle of the major classes of virus. Profiles of 101 viruses follow, each with a color illustration. The profiles are grouped by host: human, vertebrates, plants, invertebrates, fungi, bacteria, and archaea. A short paragraph discusses relevant historical facts and the role of the virus in diseases, ecosystems, and so forth. A glossary, resource list, and index provide further information. This is a very useful resource suitable for school, public, and undergraduate libraries.

Zika: From the Brazilian Backlands to Global Threatby Debora Diniz and translated by Diane Grosklaus WhittyBrazilian bioethicist and filmmaker Diniz provides an eyewitness account of the 2015 Zika epidemic in northeastern Brazil. Her narrative is largely constructed from interviews with doctors and lab scientists but, more notably, conversations with mothers whose babies suffered from congenital Zika microcephaly, an abnormally small head associated with brain damage. An important and informative book because Zika has become a growing health concern for women of reproductive age.

More Deadly Than War: The Hidden History of the Spanish Flu and the First World War by Kenneth C. DavisDavis (In the Shadow of Liberty, 2016) argues persuasively that the Spanish flu pandemic had as muchif not moreof an effect on the outcome of WWI than any military strategy. Citing plenty of primary sources, Davis lays out how the pandemic was spread, the largely ineffective efforts to curtail it, and the many ways government officials, swept up in waves of nationalism, ignored the advice of medical professionals, which ultimately made the pandemic worse. Engaging and illuminating.

Centers for Disease Control and PreventionCoronavirus COVID-19 Global Cases by Johns Hopkins CSSEKaiser Health NewsLibrary JournalMedlinePlusStat NewsWorld Health Organization

See the article here:
Setting the Record Straight: Panic and Pandemics - American Libraries

Breakthrough in Stem Cell Research: First Image of Niche Environment | Newsroom – UC Merced University News

By Lorena Anderson, UC Merced

Professor Joel Spencer and his lab have made a huge breakthrough in stem cell research.

Professor Joel Spencer was a rising star in college soccer and now he is an emerging scientist in the world of biomedical engineering, capturing for the first time an image of a hematopoietic stem cell (HSC) within the bone marrow of a living organism.

Everyone knew black holes existed, but it took until last year to directly capture an image of one due to the complexity of their environment, Spencer said. Its analogous with stem cells in the bone marrow. Until now, our understanding of HSCs has been limited by the inability to directly visualize them in their native environment until now.

This work brings an advancement that will open doors to understanding how these cells work which may lead to better therapeutics for hematologic disorders including cancer.

Understanding how HSCs interact within their local environments might help researchers understand how cancers use this same environment in the bone marrow to evade treatment.

Spencer studied biological sciences at UC Irvine where he was the captain of the mens Division 1 soccer team. He initially planned to pursue a career in professional soccer until faculty mentors opened doors for research and introduced Spencer to biophotonics the science that deals with the interactions of light with biological matter.

UC faculty were a big part of my research experience; they became mentors and friends, Spencer said. My first foray into research was as a lab tech, and that is where I met people who were doing biomedical imaging, and it just caught my wonder.

An image of a stem cell in its natural niche

Spencer left his native California to earn his Ph.D. in bioengineering at Tufts University in Boston and took a postdoctoral research position in the Wellman Center for Photomedicine at Massachusetts General Hospital and Harvard Medical School. In Boston, he learned about live-animal imaging and his wonder became a passion.

Now his emphasis is on biomedical optics: building new microscopes and new imaging techniques to visualize and study biological molecules, cells and tissue in their natural niches in living, fully intact small animals.

I work at the interface of engineering and biology. My lab is seeking to answer biological questions that were impossible until the advancements in technology we have seen in the past couple decades, he said. You need to be able to peer inside an organ inside a live animal and see whats happening as it happens.

Based on work conducted at UC Merced and in Boston, he and his collaborators including his grad student Negar Tehrani visualized stem cells inside the bone marrow of live, intact mice.

He and his collaborators have a new paper published in the journal Nature detailing the work they conducted to study HSCs in their native environment in the bone marrow.

We can see how the cells behave in their native niches and how they respond to injuries or stresses which seems to be connected to the constant process of bone remodeling, Tehrani said. Researchers have been trying to answer questions that have gone unanswered for lack of technology, and they have turned to engineering to solve those puzzles.

Its important for researchers to understand the mechanics of stem cells because of the cells potential to regenerate and repair damaged tissue.

Spencer, left, and students from his lab

Spencer returned to California three years ago, joining the Department of Bioengineering in the School of Engineering at UC Merced. Hes also an affiliate of the Health Sciences Research Institute and the NSF CREST Center for Cellular and Biomolecular Machines . This is his third paper in Nature, but the first stemming from work conducted in his current lab.

He didnt come to UC Merced just because he loves biology Spencer also joined the campus because of the students.

Now Im back in the UC system Im a homegrown UC student whos now faculty, Spencer said. As a student within the system I was able to participate in myriad opportunities, including mentorships that advanced my career. Now I try to encourage graduate and undergrad students to follow their dreams. I love being able to give them opportunities its something I really want to do for the next generation.

See the article here:
Breakthrough in Stem Cell Research: First Image of Niche Environment | Newsroom - UC Merced University News

Why Are Bat Viruses So Deadly? Answers to the Question Raised by Coronavirus Outbreak – SciTechDaily

The Australian black flying fox is a reservoir of Hendra virus, which can be transmitted to horses and sometimes humans. Credit: Linfa Wang, Duke University

Its no coincidence that some of the worst viral disease outbreaks in recent years SARS, MERS, Ebola, Marburg and likely the newly arrived 2019-nCoV virus originated in bats.

A new University of California, Berkeley, study finds that bats fierce immune response to viruses could drive viruses to replicate faster, so that when they jump to mammals with average immune systems, such as humans, the viruses wreak deadly havoc.

Some bats including those known to be the original source of human infections have been shown to host immune systems that are perpetually primed to mount defenses against viruses. Viral infection in these bats leads to a swift response that walls the virus out of cells. While this may protect the bats from getting infected with high viral loads, it encourages these viruses to reproduce more quickly within a host before a defense can be mounted.

This makes bats a unique reservoir of rapidly reproducing and highly transmissible viruses. While the bats can tolerate viruses like these, when these bat viruses then move into animals that lack a fast-response immune system, the viruses quickly overwhelm their new hosts, leading to high fatality rates.

Some bats are able to mount this robust antiviral response, but also balance it with an anti-inflammation response, said Cara Brook, a postdoctoral Miller Fellow at UC Berkeley and the first author of the study. Our immune system would generate widespread inflammation if attempting this same antiviral strategy. But bats appear uniquely suited to avoiding the threat of immunopathology.

The researchers note that disrupting bat habitat appears to stress the animals and makes them shed even more virus in their saliva, urine and feces that can infect other animals.

The Egyptian fruit bat, Rousettus aegyptiacus, is a host to the Marburg virus, which can infect monkeys and cross over into humans to cause a deadly hemorrhagic fever. Credit: Victor Corman

Heightened environmental threats to bats may add to the threat of zoonosis, said Brook, who works with a bat monitoring program funded by DARPA (the U.S. Defense Advanced Research Projects Agency) that is currently underway in Madagascar, Bangladesh, Ghana and Australia. The project, Bat One Health, explores the link between loss of bat habitat and the spillover of bat viruses into other animals and humans.

The bottom line is that bats are potentially special when it comes to hosting viruses, said Mike Boots, a disease ecologist and UC Berkeley professor of integrative biology. It is not random that a lot of these viruses are coming from bats. Bats are not even that closely related to us, so we would not expect them to host many human viruses. But this work demonstrates how bat immune systems could drive the virulence that overcomes this.

The new study by Brook, Boots and their colleagues was published this month in the journal eLife.

Boots and UC Berkeley colleague Wayne Getz are among 23 Chinese and American co-authors of a paper published recently in the journal EcoHealth that argues for better collaboration between U.S. and Chinese scientists who are focused on disease ecology and emerging infections.

As the only flying mammal, bats elevate their metabolic rates in flight to a level that doubles that achieved by similarly sized rodents when running.

Generally, vigorous physical activity and high metabolic rates lead to higher tissue damage due to an accumulation of reactive molecules, primarily free radicals. But to enable flight, bats seem to have developed physiological mechanisms to efficiently mop up these destructive molecules.

This has the side benefit of efficiently mopping up damaging molecules produced by inflammation of any cause, which may explain bats uniquely long lifespans. Smaller animals with faster heart rates and metabolism typically have shorter lifespans than larger animals with slower heartbeats and slower metabolism, presumably because high metabolism leads to more destructive free radicals. But bats are unique in having far longer lifespans than other mammals of the same size: Some bats can live 40 years, whereas a rodent of the same size may live two years.

This rapid tamping down of inflammation may also have another perk: tamping down inflammation related to antiviral immune response. One key trick of many bats immune systems is the hair-trigger release of a signaling molecule called interferon-alpha, which tells other cells to man the battle stations before a virus invades.

As shown in this model of viral infection (click to view animated GIF), when green monkey (Vero) cells are invaded by a virus, they quickly succumb because they have no interferon response. Susceptible cells (green pixels) are rapidly exposed, infected and killed (purple). Credit: Cara Brook / UC Berkeley

Brook was curious how bats rapid immune response affects the evolution of the viruses they host, so she conducted experiments on cultured cells from two bats and, as a control, one monkey. One bat, the Egyptian fruit bat (Rousettus aegyptiacus), a natural host of Marburg virus, requires a direct viral attack before transcribing its interferon-alpha gene to flood the body with interferon. This technique is slightly slower than that of the Australian black flying fox (Pteropus alecto), a reservoir of Hendra virus, which is primed to fight virus infections with interferon-alpha RNA that is transcribed and ready to turn into protein. The African green monkey (Vero) cell line does not produce interferon at all.

When challenged by viruses mimicking Ebola and Marburg, the different responses of these cell lines were striking. While the green monkey cell line was rapidly overwhelmed and killed by the viruses, a subset of the rousette bat cells successfully walled themselves off from viral infection, thanks to interferon early warning.

In the Australian black flying fox cells, the immune response was even more successful, with the viral infection slowed substantially over that in the rousette cell line. In addition, these bat interferon responses seemed to allow the infections to last longer.

Think of viruses on a cell monolayer like a fire burning through a forest. Some of the communities cells have emergency blankets, and the fire washes through without harming them, but at the end of the day you still have smoldering coals in the system there are still some viral cells, Brook said. The surviving communities of cells can reproduce, providing new targets for the the virus and setting up a smoldering infection that persists across the bats lifespan.

Brook and Boots created a simple model of the bats immune systems to recreate their experiments in a computer.

This suggests that having a really robust interferon system would help these viruses persist within the host, Brook said. When you have a higher immune response, you get these cells that are protected from infection, so the virus can actually ramp up its replication rate without causing damage to its host. But when it spills over into something like a human, we dont have those same sorts of antiviral mechanism, and we could experience a lot of pathology.

The researchers noted that many of the bat viruses jump to humans through an animal intermediary. SARS got to humans through the Asian palm civet; MERS via camels; Ebola via gorillas and chimpanzees; Nipah via pigs; Hendra via horses and Marburg through African green monkeys. Nonetheless, these viruses still remain extremely virulent and deadly upon making the final jump into humans.

In a model of viral infection (click to view animated GIF), when cells of the Australian black flying fox are invaded by a virus, some quickly wall themselves off from infection, having been forewarned by a rapid release of interferon from dying cells. This allows the cells to survive longer, but increases the number of infectious cells (red). Credit: Cara Brook / UC Berkeley

Brook and Boots are designing a more formal model of disease evolution within bats in order to better understand virus spillover into other animals and humans.

It is really important to understand the trajectory of an infection in order to be able to predict emergence and spread and transmission, Brook said.

References:

Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence by Cara E Brook Is a corresponding author , Mike Boots, Kartik Chandran, Andrew P Dobson, Christian Drosten, Andrea L Graham, Bryan T Grenfell, Marcel A Mller, Melinda Ng, Lin-Fa Wang and Anieke van Leeuwen, 3 February 2020, eLife.DOI: 10.7554/eLife.48401

Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence by Cara E Brook Is a corresponding author , Mike Boots, Kartik Chandran, Andrew P Dobson, Christian Drosten, Andrea L Graham, Bryan T Grenfell, Marcel A Mller, Melinda Ng, Lin-Fa Wang and Anieke van Leeuwen, 3 February 2020, eLife.DOI: 10.7554/eLife.48401

Other co-authors of the eLife paper are Kartik Chandran and Melinda Ng of Albert Einstein College of Medicine in New York City; Andrew Dobson, Andrea Graham, Bryan Grenfell and Anieke van Leeuwen of Princeton University in New Jersey; Christian Drosten and Marcel Muller of Humboldt University in Berlin, Germany; and Lin-Fa Wang of Duke University-National University of Singapore Medical School.

The work was funded by a National Science Foundation fellowship, the Miller Institute for Basic Research at UC Berkeley and a grant from the National Institutes of Health (R01 AI134824).

Read the rest here:
Why Are Bat Viruses So Deadly? Answers to the Question Raised by Coronavirus Outbreak - SciTechDaily

Sphere Fluidics Expands Commercial Operations to Increase Supply of Pico-Surf Surfactant for Droplet Microfluidics – BioSpace

Feb. 13, 2020 09:18 UTC

CAMBRIDGE, England--(BUSINESS WIRE)-- Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, today announced investment in the production and supply of its proprietary biocompatible surfactant, Pico-Surf, for reliable and highly stable droplet generation and processing. Sphere Fluidics will expand operations to meet demand for large-scale commercial supply of its high-performing surfactant for use in a wide range of microfluidic application workflows.

Pico-Surf is a high-quality and animal-origin-free biocompatible surfactant optimized to support the formation of aqueous solution-in-oil picodroplets. Sphere Fluidics aims to increase production of Pico-Surf by three-fold in 2020, whilst maintaining its industry-leading standards, through significant investment of resources in manufacture and quality control processes, and workforce. As part of Sphere Fluidics range of specialist chemicals, Pico-Surf is designed to work effectively and flexibly across a broad range of microfluidic systems, including the Companys proprietary single cell analysis platforms and applications, such as molecular biology assays, cell secretion assays and cell growth studies.

The unique and patented molecular structure of Pico-Surf stabilizes droplets, and retains and protects their cellular and molecular contents over a wide range of temperatures and biological conditions, helping to ensure high cell viability for improved assay performance. Droplets generated using Pico-Surf show low end point interfacial tension and critical micelle concentration in comparison to other commercially available surfactants. The purity and quality of the surfactant also enables a more efficient droplet sorting process at low voltage. The ready-to-use surfactant is available in large batches or made-to-order with ensured lot-to-lot consistency.

Dr. Marian Rehak, Vice President of Research and Development, Sphere Fluidics, said: We are enthused by the increased demand for Pico-Surf, and eager to mobilize its production to meet demand. Whilst doing so, we will ensure its very high quality control standards are maintained, meaning researchers can continue rely on Pico-Surf to create droplets that are stable and reproducible.

Rob Treanor, Director of Operations, Sphere Fluidics, commented: Sphere Fluidics world-leading expertise in picodroplet technology has enabled the development of an ever-growing range of high-performing patented consumables, vital for the successful use of microfluidic systems. All our consumable products have been designed to be platform-agnostic, so they work effectively with a number of microfluidic systems.

For further information on Pico-Surf, please visit: https://spherefluidics.com/specialist-chemicals/

For further information about Sphere Fluidics full range of consumables for microfluidics systems, please visit: https://spherefluidics.com/products/consumables/

Follow Sphere Fluidics on Twitter @SphereFluidics and LinkedIn @Sphere Fluidics Limited.

For a high-resolution image please contact Zyme Communications.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200213005316/en/

Follow this link:
Sphere Fluidics Expands Commercial Operations to Increase Supply of Pico-Surf Surfactant for Droplet Microfluidics - BioSpace

Out of Touch: Depletion of Mechanosensors Drives Wound-Healing and Cancer – TMC News – Texas Medical Center News

Additional dates:Next Event:February 11, 2020

Dr. Michael SheetzWelch Professor of BiochemistryMolecular MechanoMedicine ProgramBiochemistry and Molecular BiologyUniversity of Texas Medical BranchGalveston, TX

Out of Touch: Depletion of Mechanosensors Drives Wound-Healing and Cancer

Tuesday, February 11, 202012:30 1:30 PMBRC, 10th Floor, Room 1060 A/B

Abstract: Loss of matrix rigidity sensing in tumor cells enables transformed growth. In over forty tumor lines tested, they lack rigidity sensing complexes because components are altered (about 60% had low Tpm 2.1). The rigidity sensing complex (about 2 m in length) contracts matrix adhesions by ~100nm; and if the force generated is greater than ~25 pN, then cells can grow (Wolfenson et al., 2016. Nat Cell Bio. 18:33). However, if the surface is soft, then the cells apoptose by DAPK1 activation (Qin et al., 2018 BioRxiv. 320739). Although tumor cells grow on soft surfaces, restoration of rigidity sensing restores rigidity-dependent growth (Yang, B. et al., 2020 Nature Mat. 19: 239). Surprisingly, mechanical stretch of transformed cancer cells activates apoptosis through calpain-dependent apoptosis (Tijore et al., 2018 BioRxiv. 491746). Thus, stretch sensitivity is a weakness of cancer cells related to transformation and not to the tissue type or other factors.

Bio: Prof. Michael Sheetz has a long history in mechanobiological research and was most recently the Director of the Mechanobiology Institute at the National University of Singapore. Prior to that he was a Professor at Columbia University where he headed a program in nanomedicine. At Duke University Medical School, he was Chair of Cell Biology from 1990 to 2000. He has received many awards including the Lasker Prize, Wiley and Massry Prizes.

Excerpt from:
Out of Touch: Depletion of Mechanosensors Drives Wound-Healing and Cancer - TMC News - Texas Medical Center News